GI Stents & Drainage Devices
Self-expanding metal stents, biliary drainage catheters, and lumen-apposing metal stents used in ERCP, EUS, and palliative GI obstruction management procedures.
Market snapshot
These figures describe Endoscopy & GI Devices (4.8.5), the segment that GI Stents & Drainage Devices sits within — not GI Stents & Drainage Devices on its own.
Within surgical & medical instruments (NAICS 339112); the Census Bureau does not split out endoscopy/GI, so the segment is not separately sized.
Business model & economics
Revenue model
Endoscope systems plus recurring accessories and disposables
Key economics
- Recurring revenue
- High
- EBITDA margin
- 20–30%
- Capex intensity
- High
recurring accessories and single-use scopes
Characteristics
- Olympus dominates flexible endoscopes.
- Shift to single-use scopes on infection-control concerns.
- GI procedure volumes and aging drive demand.
Geographic concentration
Endoscopy and GI device manufacturing concentrates in Minnesota, Massachusetts, and California — the three med-tech hubs anchoring U.S. device design and production.
U.S. Census Bureau — 2022 County Business Patterns (establishments by state), NAICS 339112. Concentration shown by location quotient.
M&A deal context
Who’s acquiring
- Endoscopy & GI strategics
- Single-use-scope innovators' acquirers
- Diversified medtech platforms
What’s driving deals
- Single-use endoscope transition.
- GI procedure-volume and aging demand.
- Acquisition of interventional-GI innovation.
Find GI Stents & Drainage Devices acquisition targets
Search Acquisera’s index for companies classified under GI Stents & Drainage Devices (4.8.5.5) and build a targeted deal pipeline.
Search companies